SKIOM, a science-driven skincare startup co-founded by Dr. Gautam Banerjee and Balaknath Datta, is preparing for its official launch this November. Built on the principles of microbiome science, the startup aims to redefine skincare in India with formulations designed to support the skin’s natural ecosystem rather than disrupt it.
Founded in February 2024, the name SKIOM itself is derived from “skin microbiome,” reflecting the brand’s scientific foundation. The founders identified a gap in India’s skincare market for science-backed, clinically validated products designed for Indian consumers.
Dr. Banerjee, a Ph.D. from CSIR and postdoctoral researcher from Yale University, brings over three decades of R&D leadership experience from organizations like Hindustan Unilever Limited and the Tata Group. His co-founder, Balaknath Datta, an MBA in Marketing, has held senior roles across SABMiller, AB InBev, and other global firms, specializing in category innovation, and market expansion. Together, they combine scientific expertise with commercial insight to build a purpose-led, evidence-based skincare brand.
SKIOM’s launch portfolio features four microbiome-safe leave-on products — Acne Shield Cream, Restore Skin Aging Cream, Moisture Guard, and Biobalance Sunscreen. Each formulation incorporates prebiotic and microbiome-regulatory actives aimed at addressing acne, inflammation, hydration, and UV protection.
Unlike conventional rinse-off products, SKIOM’s leave-on format ensures sustained delivery of active ingredients, enhancing skin performance over time.
The company’s long-term plan includes expanding into categories like serums, scalp care, men’s grooming, and baby skincare, all built on its microbiome-first philosophy. The startup claims, every product undergoes rigorous safety checks, dermatologist testing, and independent clinical validation before market release.
Microbiome-focused skincare long embraced in markets like Korea, Japan, and the U.S. is still emerging in India. Global data suggests that over 60% of consumers in Western markets are already aware of microbiome-safe skincare, while India is witnessing early-stage adoption.
As a direct-to-consumer brand, SKIOM is launching via its own website and select marketplaces before expanding to clinics and retail partners.
Alongside product development, the company is also investing in consumer awareness, creating digital content, collaborations, and academic outreach programs to promote awareness around microbiome associated health and informed skincare choices.
